Jun 18, 2025
Mallinckrodt Announces Publication of Real-World Insights on Patient Experience with Acthar® Gel (repository corticotropin injection) Single-Dose Pre-filled SelfJect(TM) Injector
Jun 13, 2025
Mallinckrodt and Endo Shareholders Approve Combination to Create a Global, Scaled, Diversified Pharmaceuticals Leader
Jun 09, 2025
Mallinckrodt, Endo Announce Planned Leadership Team for Merged Company
May 14, 2025
Mallinckrodt Presents Data on Real-World Outcomes with Acthar® Gel (repository corticotropin injection) at the International Congress on Systemic Lupus Erythematosus (LUPUS 2025)
May 13, 2025
Mallinckrodt and Endo Announce Significant Progress in Proposed Merger
May 06, 2025
Mallinckrodt plc Reports First Quarter 2025 Financial Results and Reaffirms Full-Year Guidance
Apr 23, 2025
Mallinckrodt to Present Data on TERLIVAZ® (terlipressin) for Injection at the 2025 Digestive Disease Week (DDW) Annual Meeting
Apr 10, 2025
Mallinckrodt plc to Report Earnings Results for First Quarter 2025
Mar 13, 2025
Mallinckrodt plc Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Provides 2025 Guidance
Mar 13, 2025
Mallinckrodt and Endo to Combine to Create a Global, Scaled, Diversified Pharmaceuticals Leader
Mar 10, 2025
Mallinckrodt plc Reschedules Release of Fourth Quarter and Fiscal Year 2024 Financial Results to Thursday, March 13, 2025
Dec 02, 2024
Mallinckrodt Completes Divestiture of Therakos® Business
Nov 18, 2024
Mallinckrodt Presents Data on TERLIVAZ® (terlipressin) for Injection in Patients with Hepatorenal Syndrome (HRS) at the 2024 American Association for the Study of Liver Diseases (AASLD) Annual Meeting
Nov 14, 2024
Mallinckrodt to Present at Jefferies London Healthcare Conference
Nov 05, 2024
Mallinckrodt plc Reports Third Quarter 2024 Financial Results and Raises Full Year Guidance
Oct 29, 2024
Mallinckrodt Presents Data on TERLIVAZ® (terlipressin) for Injection in Patients with Hepatorenal Syndrome-Acute Kidney Injury (HRS-AKI) at the American College of Gastroenterology (ACG) Annual Meeting
Oct 26, 2024
Mallinckrodt Presents Data on TERLIVAZ® (terlipressin) for Injection in Patients with Hepatorenal Syndrome (HRS) at Kidney Week 2024
Oct 10, 2024
Mallinckrodt Announces an Expanded Rollout of the INOmax® EVOLVE(TM) DS Delivery System in U.S. Hospitals
Sep 17, 2024
Mallinckrodt Announces Publication of Human Factors Studies and Arthritis Foundation Ease of Use® Certification of Acthar® Gel (repository corticotropin injection) Single-Dose Pre-filled SelfJect(TM) Injector
Aug 06, 2024
Mallinckrodt plc Reports Second Quarter 2024 Financial Results and Raises Full Year Guidance